NetworkNewsBreaks

MondayOct 19, 2026 3:21 pm

NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Featured in Men’s Fitness Article Examining Unbuzzd Clinical Trial Results

Quantum BioPharma (NASDAQ: QNTM) was featured in a Men's Fitness article by Lakshan Weeraratne examining clinical trial results for Unbuzzd, an alcohol recovery formulation developed by Quantum and licensed to Unbuzzd Wellness. The article highlights findings from a company-sponsored, placebo-controlled study involving 26 healthy adults, with 24 completing both treatment sessions. Researchers reported significantly lower estimated blood alcohol concentrations at several time points, improved self-rated alertness and reduced headache severity on certain assessments. Among 17 participants identified as rapid responders, the average percentage decline in estimated blood alcohol during the first 30 minutes was 40.7% greater with Unbuzzd than with…

Continue Reading

MondayOct 19, 2026 12:44 pm

NetworkNewsBreaks – Greenland Mines Ltd. (NASDAQ: GRML; FSE: HK6) Begins Trading on Xetra to Expand Global Investor Access 

Greenland Mines (NASDAQ: GRML; FSE: HK6), a Greenland-focused critical-minerals developer, announced that its common stock has begun trading on Xetra, the electronic trading platform operated by Deutsche Börse AG in Germany. MWB Fairtrade AG will serve as designated sponsor, supporting trading liquidity and turnover. The addition of Xetra is intended to broaden the company's investor base, improve liquidity and enhance price discovery by providing greater access to European institutional and retail investors. Xetra's international trading network also provides access to investors in Asia and the Middle East, including through trading participants in Hong Kong and the United Arab Emirates. The…

Continue Reading

MondayOct 19, 2026 11:07 am

NetworkNewsBreaks – ECGI Holdings Inc. (OTC: ECGI) Highlights Avanta Acquisition and Growing Opportunities in $5.3 Trillion U.S. Healthcare Market 

ECGI Holdings (OTC: ECGI) is featured in an AINewsWire editorial examining the shift toward preventive, coordinated healthcare and the growing role of artificial intelligence in improving patient outcomes and managing costs. The editorial highlights ECGI's acquisition of Avanta Group, a developing integrated healthcare platform encompassing Medicare Advantage insurance, management services, AI-enabled technology, consumer health and healthcare infrastructure. The acquisition positions ECGI to pursue opportunities in a U.S. healthcare market that reached $5.3 trillion in 2024, with Medicare Advantage payments projected to total $574 billion in 2026. The editorial also discusses the potential for integrated technology and care coordination to improve…

Continue Reading

MondayOct 19, 2026 9:45 am

NetworkNewsBreaks – Frontieras North America and Cadillac Formula 1(R) Team Announce Multi-Year Global Energy Transformation Partnership

Frontieras North America announced a multi-year global partnership with the Cadillac Formula 1(R) Team, naming Frontieras as the team's Official Energy Transformation Partner. The collaboration brings together two American companies focused on advancing innovation in energy and motorsports, with a shared commitment to challenging established industry practices. The Cadillac Formula 1(R) Team, formed by TWG Motorsports and General Motors (NYSE: GM), is the first new team to enter the Formula 1(R) grid in a decade. Frontieras, developer of the FASForm(TM) advanced energy technology, will leverage the global Formula 1(R) platform to expand its visibility and build relationships with institutions, investors…

Continue Reading

MondayOct 19, 2026 9:20 am

NetworkNewsBreaks – TransCode Therapeutics, Inc. (NASDAQ: RNAZ) to Present Updated Phase 1a TTX-MC138 Clinical Data at ESMO Congress 2026

TransCode Therapeutics (NASDAQ: RNAZ), a clinical-stage company developing immuno-oncology and RNA-based therapeutics for high-risk and advanced cancers, announced that a poster featuring its lead therapeutic candidate, TTX-MC138, will be presented at the European Society for Medical Oncology ("ESMO") Congress 2026 on Oct. 23 in Madrid, Spain. The presentation will highlight the latest clinical update from the Phase 1a trial evaluating TTX-MC138 in patients with advanced solid tumors. TTX-MC138 is an investigational therapeutic designed to target miR-10b, a microRNA associated with metastatic disease progression. To view the full press release, visit https://nnw.fm/sGqsS About TransCode Therapeutics  TransCode Therapeutics is a clinical stage…

Continue Reading

MondayOct 19, 2026 9:00 am

NetworkNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF; FSE: Z58) Extends Confirmed Phosphate Strike Length to Over 3.3 Kilometers at Murdock Mountain

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF; FSE: Z58), a British Columbia-based organic sedimentary phosphate exploration company, announced that drill hole MM26-11 intersected 28.7 meters of the target Meade Peak Member, with visual indications of the Upper Phosphate Zone. The hole is located approximately 315 meters southwest of MM26-10, which previously intersected 27 meters of Meade Peak, including 3.60 meters grading 10.89% P2O5. The latest results extend the confirmed strike length of phosphate mineralization to more than 3.3 kilometers, supporting the company’s geological…

Continue Reading

FridayOct 16, 2026 3:59 pm

NetworkNewsBreaks – Numa Numa Resources Inc. Builds Multiproject Strategy Around Bougainville’s Mineral Resources

Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements. Numa Numa Resources is advancing a multiproject development strategy in Bougainville, Papua New Guinea, with its flagship Panguna copper-gold mine redevelopment positioned to benefit from rising metals prices and growing global demand for critical resources. Historically operated by Rio Tinto from 1972 to 1989, Panguna produced approximately 3 million tonnes of copper and 9.3 million ounces of gold before operations ceased amid landowner grievances and civil conflict. The company cites historical reserve estimates of 5.3 million metric tons of copper and 547.15 metric tons of gold, while…

Continue Reading

FridayOct 16, 2026 3:37 pm

NetworkNewsBreaks – Nano-X Imaging Ltd. (NASDAQ: NNOX) Highlights Insider Buying Alongside Its Integrated Healthcare Technology Strategy

Recent SEC Form 4 filings disclosed open-market purchases of Nano-X Imaging Ltd.’s (NASDAQ: NNOX) (“Nanox”) ordinary shares by CEO Erez Meltzer and Board Director Dan Suesskind, adding to purchases reported in recent months by Meltzer, Suesskind and Board Director Nogah Keinan. The transactions reflect share purchases made directly in the open market by the company’s senior leadership and board members, with additional details available in the respective SEC filings. This comes as Nanox continues to advance its integrated medical imaging and healthcare services platform, which combines proprietary digital X-ray technology, AI-powered imaging analytics, cloud-based software, remote radiology services and healthcare…

Continue Reading

FridayOct 16, 2026 3:15 pm

NetworkNewsBreaks – Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N) Partners with Canadian Consortium on AI-Driven Cancer Research

Disseminated on behalf of Redwood AI Corp. and may include paid advertising. Redwood AI (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N) has joined a Canadian oncology research consortium as a co-applicant in a competitive Terry Fox Research Institute grant supporting the development of Onco-Innovations’ SynoGraph(TM) artificial intelligence platform. The research project will investigate whether causal AI, combined with preclinical research and real-world clinical, genomic and imaging data, can improve predictions of how investigational therapies may perform in human trials. Redwood AI will contribute proprietary data integration, feature engineering and physicochemical modelling methods, working alongside Onco-Innovations and academic research partners that will supply…

Continue Reading

FridayOct 16, 2026 2:36 pm

NetworkNewsBreaks – Silynxcom Ltd. (NYSE American: SYNX) Expands European Defense Presence with New CLARUS Orders

Silynxcom (NYSE American: SYNX) has received two consecutive purchase orders totaling approximately $400,000 from a leading global defense company for its CLARUS In-Ear Headset product family, with the systems designated for a European army. The modular CLARUS platform combines hearing protection, tactical communications, an in-ear microphone and situational awareness features, including drone detection. According to CEO Nir Klein, the orders reflect the company’s established relationship with a major defense customer and continued recognition of its products among European military organizations. The purchases also support Silynxcom’s efforts to expand its presence in European defense markets as military and security customers seek…

Continue Reading